Ivey Business School (Canada)
-
Change at Pfizer: Jeff Kindler (C) Post Wyeth Acquisition Organization
Michael J. Rouse; Chander SehgalCase IVEY-9B10M054-EStrategyThis case is a supplement to Change at Pfizer: Jeff Kindler (A).Starting at €5.74
-
Fuyao Glass: Global Strategy for U.S. Country Risk
Vernon Ning Hsu; Hugh Thomas; Joyce L. Wang; Wu YuhuiCase IVEY-9B19M111-EStrategyThe chairman of Fuyao Glass Industry Group Co. Ltd. was pleased with his company’s financial results for the first half of 2018. Two years earlier, the organization’s subsidiary, Fuyao Glass America Inc., had completed the construction of the largest autoStarting at €8.20
-
Change at Pfizer: Jeff Kindler (A)
Michael J. Rouse; Chander SehgalCase IVEY-9B10M014-EStrategyPfizer Inc., the largest research-based drug company in the world, was faced with multiple challenges, including fierce court battles with generic drug companies over the patents of Lipitor, reduced productivity from research and development, and a changing external health care environment globally, with growing importance of emerging markets. These challenges were set within a business environment characterized by multi-level change and uncertai...Starting at €8.20
-
Change at Pfizer: Jeff Kindler (B) The Wyeth Acquisition
Michael J. Rouse; Chander SehgalCase IVEY-9B10M053-EStrategyThis supplement to Change at Pfizer: Jeff Kindler (A) deals with Pfizer’s 2009 acquisition of Wyeth — the first mega-acquisition since the world economic crisis.Starting at €5.74